Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Biobased specialty firm Amyris will wrap up a years-long vitamin E deal by selling its royalty rights to partner DSM for $57 million. Amyris will no longer be in the vitamin E business, but the two firms will continue to work together. In 2017, Amyris sold its plant in Brotas, Brazil, to DSM. Now DSM will produce Amyris’s molecules for markets including flavors and fragrances, skin care, sweeteners, and cannabinoids. That deal will be worth up to $40 million over the next 3 years, Amyris says.
This article has been sent to the following recipient: